Clora
@MeetCloraThe best place to discover, build, and manage on-demand life science teams.
Similar User
@Biotech2050Pod
@rahulc
@aspenbio
@Pittcon
@FabricGenomics
@Livelyhsa
@labgeni_us
@alder_riley
@CTgreenbuilding
The #obesity treatment sector is booming - @MetseraInc $215M Series B brings its funding to $500M+ since April. Major players like @bioagelabs, @kaileratx, and SixPeaks are driving growth, with @MorganStanley projecting the market to hit $105B by 2030: ow.ly/2gSV50UcYCp
Join @rahulc on @Biotech2050Pod for a conversation with Bharatt Chowrira & @EricElenko of @PureTechH on their unique R&D model, the rise of @KarunaTx, & lessons in patient-centered innovation. Tune in now!
Dive into the latest #Biotech2050 episode! Host @rahulc joins Bharatt Chowrira, CEO & @EricElenko, Co-Founder & President of @PureTechH as they share lessons on innovative R&D, tackling challenges, & Karuna Therapeutics' journey. Listen: on.soundcloud.com/qM5bpRmzwU8auR… #Biotech #Podcast
Only 48% of #biotech roles are filled, and #hiring can take 105+ days. Our new eBook reveals faster, flexible staffing solutions to keep R&D on track. Discover your options—download today: ow.ly/gMYs50U85aP
.@Septerna_Inc's recent #IPO raised an impressive $288M. This follows strong IPOs by Zenas Biopharma, @MBXBio, and @BicaraTx, signaling renewed investor confidence in early-stage #biotech and a warming market for innovation in #healthcare : ow.ly/osA350U5uo4
Rob Williamson, CEO of @Triumvirainc, joins @rahulc to discuss his path from economics to #biotech, #celltherapy breakthroughs, navigating capital markets, and the role of #AI in #healthcare. Don’t miss the new episode of @Biotech2050Pod - tune in using the link below.
📢 New #Biotech2050! Host @rahulc talks with Rob Williamson, CEO of @Triumvirainc, on biotech’s highs & lows, solid tumor breakthroughs, market trends & AI’s role in healthcare. Must-listen for biotech fans! 🔬🎧 Listen here: on.soundcloud.com/TumKdPqYnMtxya… #BiotechPodcast #CellTherapy
Hear @rahulc talk with Gene Mack, Interim CEO & CFO of @GainThera, about his shift from aspiring neurosurgeon to #biotech leader. Gene discusses GT02287, Gain’s promising asset targeting disease modification in #Parkinsons. Tune in!
Tune in as @rahulc hosts Gene Mack, Interim CEO & CFO @GainThera! Discover his journey from neurosurgery to biotech & his mission to redefine Parkinson’s treatment w/ disease-modifying innovation! Listen: on.soundcloud.com/qkxzDEUsx5wcmV… #Neuroscience #Biotech2050 #Parkinsons #Biotech
📈@McKesson's 2024 Cell & Gene Therapy Report reveals record CGT approvals in 2023 and an expanding pipeline targeting neurological, cardiovascular, and metabolic conditions. See the full report: inspirogene.com/wp-content/upl… #celltherapy #genetherapy #oncology #geneticmedicine
We are excited to launch InspiroGene by McKesson's inaugural 2024 Cell and Gene Therapy (CGT) Report, full of data and insights on the #CGT landscape and its future trajectory. Download the report here: inspirogene.com/2024cgtreport/
Our CEO @rahulc sits down with @PavanCheruvuMD, CEO of @BitterrootBio, to discuss revolutionizing #cardiovascularhealth. Hear Pavan share his insights on combating #atherosclerosis with cutting-edge #cardioimmunology. Tune in!
Paving the way for the future of cardiovascular health! In the latest #Biotech2050 episode, @rahulc chats with @PavanCheruvuMD, CEO of @BitterrootBio, about groundbreaking innovations in cardio-immunology & tackling atherosclerosis. #Healthcare #Atherosclerosis #Podcast
Flagship Pioneering recently launched @mirai_bio to transform #geneticmedicine. Focused on innovative lipid nanoparticle design, Mirai supports #biotech partners with AI-driven solutions to de-risk and accelerate #genetherapy advancements.
We are Mirai Bio: an open end-to-end platform company for co-creation of #GeneticMedicines. Using proprietary data & #MachineIntelligence, we can co-optimize delivery, design & manufacturing to accelerate development of novel medicines with our partners: miraibio.com/news/flagship-…
Congrats to our client Pathos AI on closing a $62M Series C round to drive innovation in AI-powered #drugdevelopment. With this funding, Pathos will advance precision #oncology trials and patient selection, pushing boundaries in #clinicaldevelopment : ow.ly/HU9T50TWozB
Our CEO @rahulc chats with Abe Ceesay, CEO of Rapport Therapeutics, on how precision #neuroscience is driving revolutionary treatments for neurological disorders like focal #epilepsy. Listen now using the link below.
✨ Ready for the future of precision neuroscience? Abe Ceesay, CEO of Rapport Therapeutics, & #Biotech2050 host @rahulc dive into treatments for neurological disorders like focal epilepsy. Don’t miss these insights! Listen: on.soundcloud.com/bfTa3VLAE46yPK… #PrecisionNeuroscience #biotech
Huge congrats to @SomiteAi, a Clora client, on their feature in @Forbes! Read all about their work transforming #stemcell biology with #AI scaling laws, bringing us closer to scalable cell replacement therapies: forbes.com/sites/gilpress…
Forbes: Somite's AI-Powered Path to Human Spare Parts forbes.com/sites/gilpress… Great coverage of @SomiteAi in @Forbes covering our progress to date (Orphan Drug Designation granted by @US_FDA, $10m pre-seed raise). Excited to make great strides on our mission to transform…
Dr. @dave_bearss, Co-Founder & CEO of @Halia_Tx, joins @rahulc on the @Biotech2050Pod #podcast to discuss Halia’s groundbreaking work on Alzheimer’s & neuroinflammation therapies. Tune in using the link below. #biotech #neurodegeneration #innovation
Don't miss this #Biotech2050 episode! @dave_bearss, CoFounder & CEO of @Halia_Tx, shares how they're leading the fight against Alzheimer’s w/ pioneering genetic discoveries & innovative therapies. Hosted by @rahulc Listen: on.soundcloud.com/Jn2APTDkoNxUye… #BiotechPodcast #AlzheimersCure
🔬 @FlagshipPioneer announced its 8th #venturefund, totaling $2.6 billion! More here: ow.ly/UOTh50SEyMr We're excited to continue supporting @PioneeringMeds, Flagship's in-house R&D and Clora client, as they continue to innovate and invest in game-changing technologies.
When should you hire a FTE, engage a consultant, or use a CRO? Choosing the right staffing model can make or break your R&D. Balance cost, agility & control with our expert guidance and start your path to better development outcomes. Access the report: ow.ly/Sf3A50Sya4H
After a tough 2023, #biotech #IPOs have rebounded in early 2024 with companies like @AltoNeuro and ArriVent Biopharma going public. This resurgence is critical for advancing innovative therapies. But will this trend continue? Read more in @BioPharmaDive: ow.ly/I70G50Sa304
We're thrilled to see our client @formationbio join forces with @sanofi and @OpenAI! This groundbreaking collaboration aims to leverage #AI to revolutionize #drugdevelopment, creating custom AI-powered solutions for more efficient, innovative treatments: ow.ly/ZHEl50S14GE
Clora CEO @rahulc sits down with @Ptipirneni, CEO of @MorphicTx on a new episode of @Biotech2050Pod Praveen shares his expertise on the current state of #autoimmune therapies and Morphic's pioneering integrin discovery platform. Tune in using the link below.
Join @rahulc and Praveen Tipirneni, CEO of Morphic Therapeutic , as they delve into the future of autoimmune therapies and driving innovation in biotech. Don't miss this insightful discussion! #Biotech #AutoimmuneTherapies #Innovation Listen now: on.soundcloud.com/9ZTpn4UX7LKL2Y…
We're excited to attend #BIO2024 next week and connect with #biotech experts and pioneers in the industry. We will be sharing how Clora is derisking #drugdevelopment by modernizing #hiring in our industry. Send us a message to schedule time to connect with our CEO @rahulc
United States Trends
- 1. UConn 14,2 B posts
- 2. Sharon Stone 6.829 posts
- 3. Thankful 72,1 B posts
- 4. #RTXOn 13,3 B posts
- 5. Man City 72,2 B posts
- 6. Hezbollah 201 B posts
- 7. Happy Thanksgiving 32,7 B posts
- 8. Dan Hurley 5.650 posts
- 9. Newsom 64,5 B posts
- 10. #PMSLive 5.842 posts
- 11. Whitmer 2.862 posts
- 12. Venmo 25,3 B posts
- 13. Feyenoord 59,2 B posts
- 14. #RussianBankCollapse 6.144 posts
- 15. Arsenal 198 B posts
- 16. Lebanon 215 B posts
- 17. Manchester City 56,8 B posts
- 18. Hochul 3.122 posts
- 19. Newscum 8.700 posts
- 20. Jay Inslee N/A
Something went wrong.
Something went wrong.